Old Web
English
Sign In
Acemap
>
authorDetail
>
Kelvin GrootObbink
Kelvin GrootObbink
Institute of Medical and Veterinary Science
Imatinib
Medicine
Nilotinib
Cohort
Immunology
4
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
2012
British Journal of Cancer
Jueqiong Wang
Timothy P. Hughes
Chung H. Kok
Verity A. Saunders
Amity Frede
Kelvin GrootObbink
Michael Osborn
Andrew A. Somogyi
Richard J. Dandrea
Deborah L. White
Show All
Source
Cite
Save
Citations (19)
The Strategy of Early Nilotinib Switch Based on Failure to Achieve Optimal Molecular Targets on Imatinib May Not Overcome the Negative Impact of a Low OCT-1 Activity in De-Novo CP-CML Patients
2011
Blood
Deborah L. White
Verity A. Saunders
Amity Frede
Kelvin GrootObbink
Cassandra Slader
David T. Yeung
Michael Osborn
Anthony K. Mills
Andrew Grigg
Timothy P. Hughes
Show All
Source
Cite
Save
Citations (1)
Non-Steroidal Anti-Inflammatory Drugs and Imatinib; Drug Interactions That May Impact Efficacy,
2011
Blood
Jueqiong Wang
Timothy P. Hughes
Chung H. Kok
Verity A. Saunders
Amity Frede
Kelvin GrootObbink
Michael Osborn
Andrew A. Somogyi
Richard J. D'Andrea
Deborah L. White
Show All
Source
Cite
Save
Citations (0)
Early Switching From Imatinib to Nilotinib In CML Patients Failing to Achieve Early Molecular Targets May Not Be An Effective Approach In Patients with Very Low OCT-1 Activity: A TIDEL II Sub-Study
2010
Blood
Deborah L. White
Verity A. Saunders
Amity Frede
Kelvin GrootObbink
Cassandra Slader
David T. Yeung
Michael Osborn
Anthony K. Mills
Andrew Grigg
Timothy Hughes
Show All
Source
Cite
Save
Citations (3)
1